People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Himmel named ChromaDex CEO; Pinney reorganizes senior management; FDA vet Chappell jumps to Greenleaf; more People In Brief.
You may also be interested in...
ChromaDex Looks To Pharma Model For Commercializing Supplement Research
Nutritional ingredient developer ChromaDex is employing a pharma-style business model to expand its R&D into finished dietary supplements – with a long-term eye on pharmaceutical products. The firm’s recent hire of CEO Jeffrey Himmel was a significant step into the consumer products arena.
ChromaDex Looks To Pharma Model For Commercializing Supplement Research
Nutritional ingredient developer ChromaDex is employing a pharma-style business model to expand its R&D into finished dietary supplements – with a long-term eye on pharmaceutical products. The firm’s recent hire of CEO Jeffrey Himmel was a significant step into the consumer products arena.
People In Brief
ChromaDex shakes up management; Perrigo adds corporate responsibility head; Office of Dietary Supplements adds 2 scientists; Oragenics adds adviser; Kidd joins Doctor's Best; Life Extension promotes Bristol-Myers vet; food safety experts support FDA’s Taylor.